Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Côte d’Ivoire
- 31 January 2005
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 32 (1) , 60-66
- https://doi.org/10.1016/j.jcv.2004.07.008
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoireAIDS, 2003
- Accuracy of the TRUGENEHIV-1Genotyping KitJournal of Clinical Microbiology, 2003
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Non-Subtype B Human Immunodeficiency Virus Type 1 from UgandaJournal of Clinical Microbiology, 2001
- Human Immunodeficiency Virus Type 1 Drug Resistance Testing: a Comparison of Three Sequence-Based MethodsJournal of Clinical Microbiology, 2001
- Performance of the Applied Biosystems ViroSeq Human Immunodeficiency Virus Type 1 (HIV-1) Genotyping System for Sequence-Based Analysis of HIV-1 in Pediatric Plasma SamplesJournal of Clinical Microbiology, 2001
- High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'IvoireJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d′IvoireAIDS, 1999